Results 61 to 70 of about 283,903 (204)
Clinics, 2018 OBJECTIVES: Hospitalized patients with cancer are at high risk of developing venous thromboembolism, and the risk increases with pregnancy. The aim of this study was to apply a thromboprophylaxis protocol with a venous thromboembolism risk score for ...
Eliane Azeka Hase +4 more
doaj +1 more source
Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review. [PDF]
, 2019 BACKGROUND Vitamin K antagonists (VKA) are the most widely used anticoagulants, and bridging is commonly administered during periprocedural VKA interruption.
Whitaker, Evans +3 more
core +2 more sources
Haematologica, 2018 Long-term, low-grade inflammation does not seem to be a risk factor for venous thromboembolism. The impact of acute inflammation, regardless of cause, on risk of venous thromboembolism is scarcely studied.
Gro Grimnes +5 more
doaj +1 more source
Pulmonary thromboembolism in a patient with myotonic dystrophy type 1
Annals of Indian Academy of Neurology, 2012 Thromboembolism is a rare complication in patients with myotonic dystrophy. While immobilization of patients with advanced disease predisposes to high risk for venous thromboembolism, hypercoagulability could account for venous thromboembolism in ...
Joong-Yang Cho +6 more
doaj +1 more source
Multiple cerebral infarctions in the context of malignancy [PDF]
, 2015 Coagulation disorders are common in patients with malignancy, sometimes leading to arterial and venous thrombosis. Such patients are therefore at increased risk for ischaemic stroke.
Paris, Etienne Mark
core
Predictors and outcomes of recurrent venous thromboembolism in elderly patients [PDF]
, 2018 BACKGROUND: Little is known about predictors and outcomes of recurrent venous thromboembolism in elderly patients. METHODS: We prospectively followed up 991 patients aged ≥65 years with acute venous thromboembolism in a multicenter Swiss cohort study ...
Frauchiger, Beat +44 more
core +3 more sources
Venous thromboembolism in women [PDF]
Vascular Medicine, 2008 Abstract The risk of venous thromboembolism (VTE) varies throughout a woman’s life and is associated primarily with underlying hormonal exposure. Alteration in hemostatic mechanisms, including resistance to activated protein C, may explain this altered risk.
openaire +2 more sources
, 2023 Alpha2-plasmin inhibitor (A2PI) is the main physiological inhibitor of plasmin. In the final phase of coagulation, activated factor XIII (FXIIIa) cross-links A2PI to fibrin and it has been shown that only cross-linked A2PI can efficiently inhibit ...
Dauda, Marriam Akua Amprofua
core